Search bioRxiv⌕ Search

Biology subjects

Hulser, M. L.

Publications and source records attributed to Hulser, M. L..

2 recordsLinked to original sources

Phospholipase D1 and Phosphatidic Acid are required for MVE Fusion and Exosome Secretion

Extracellular vesicles (EVs) mediate critical intercellular communication, yet the molecular mechanisms that govern multivesicular endosome (MVE) fusion with the plasma membrane and exosome release remain poorly understood. Phospholipase D1 (PLD1) produces phosphatidic acid (PA), a lipid involved in membrane remodeling, but when and how PLD1 and PA act during exosome secretion has not been defined. Here, we used immunofluorescence and total internal reflection fluorescence microscopy (TIRFM) to track individual CD63+ MVEs together with fluorescent PLD1 or a PA reporter (GFP-PASS) in A549 cells. PLD1 localized to CD63+ MVEs during visiting, docking, and fusion. Inhibition or knockdown of PLD1 significantly reduced MVE fusion frequency and decreased the number of secreted small EVs, while causing only a modest reduction in vesicle availability at the plasma membrane. PLD1 inhibition also increased the number of membrane-proximal lysosomes, suggesting that MVEs are diverted toward degradation when fusion is impaired. Meanwhile, PA dynamics were stage-specific: PA remained low on visiting vesicles, gradually accumulated during docking, and exhibited a sharp spike followed by loss during fusion. PA has been reported to stabilize negative curvature and potentially play a role during fusion. To test whether PA influences fusion pore behavior, we quantified CD63 decay duration (t1/2) for individual fusion events. K-means clustering revealed that vesicles with longer decay durations had higher PA levels, whereas short-decay events showed minimal PA. The PA intensity correlated positively with decay duration, while cytosolic GFP did not, indicating a specific relationship between PA and exosome release rates. Furthermore, pharmacological activation of PLD1 increased the proportion of long-decay events. Together, these findings demonstrate that PLD1-generated PA regulates MVE fate at two levels: it promotes the docking-to-fusion transition and prolongs exosome release. This identifies a lipid-based mechanism that controls both the efficiency and kinetics of exosome secretion. SIGNIFICANCE STATEMENTExosome release is essential for cell-cell communication in processes such as development, immunity, and cancer. However, the mechanism that determines whether a multivesicular endosome fuses with the plasma membrane to release exosome cargo remains unclear. We identified a lipid-based mechanism that regulates both fusion and the rate of content release. We show that phospholipase D1 (PLD1) and its product phosphatidic acid (PA) act at late stages of exosome secretion: PLD1 promotes the docking-to-fusion transition and PA levels quantitatively correlate with content release rate, suggesting that PA stabilizes the pore. These findings demonstrate that lipids can control secretion frequency and kinetics, providing a new framework for understanding and modulating exosome output.

biophysics↗

Phospholipase D1 Produces Phosphatidic Acid at Sites of Secretory Vesicle Docking and Fusion

Phospholipase D1 (PLD1) activity is essential for the stimulated exocytosis of secretory vesicles where it acts as a lipid-modifying enzyme to produces phosphatidic acid (PA). PLD1 localizes to the plasma membrane and secretory vesicles, and PLD1 inhibition or knockdowns reduce the rate of fusion. However, temporal data resolving when and where PLD1 and PA are required during exocytosis is lacking. In this work, PLD1 and production of PA are measured during the trafficking, docking, and fusion of secretory vesicles in PC12 cells. Using fluorescently-tagged PLD1 and a PA-binding protein, cells were imaged using TIRF microscopy to monitor the presence of PLD1 and the formation of PA throughout the stages of exocytosis. Single docking and fusion events were imaged to measure the recruitment of PLD1 and the formation of PA. PLD1 is present on mobile, docking, and fusing vesicles and also colocalizes with Syx1a clusters. Treatment of cells with PLD inhibitors significantly reduces fusion, but not PLD1 localization to secretory vesicles. Inhibitors also alter the formation of PA; when PLD1 is active, PA slowly accumulates on docked vesicles. During fusion, PA is reduced in cells treated with PLD1 inhibitors, indicating that PLD1 produces PA during exocytosis.

cell biology↗